about
Improving outcomes after cardiac arrest using NO inhalationAcute respiratory distress syndrome and lung injury: Pathogenetic mechanism and therapeutic implicationVentilatory strategies and supportive care in acute respiratory distress syndromeInhaled therapy for the management of perioperative pulmonary hypertensionPulmonary vascular disease related to hemodynamic stress in the pulmonary circulation.Management of refractory hypoxemiaInhaled nitric oxide therapy and risk of renal dysfunction: a systematic review and meta-analysis of randomized trialsNitrite signaling in pulmonary hypertension: mechanisms of bioactivation, signaling, and therapeuticsIntravenous administration of piceatannol, an arginase inhibitor, improves endothelial dysfunction in aged miceNitric oxide-loaded echogenic liposomes for treatment of vasospasm following subarachnoid hemorrhage.Nitric oxide-loaded echogenic liposomes for nitric oxide delivery and inhibition of intimal hyperplasia.Liposomal modular complexes for simultaneous targeted delivery of bioactive gases and therapeuticsInhaled NO accelerates restoration of liver function in adults following orthotopic liver transplantation.Hydrogen sulfide attenuates myocardial ischemia-reperfusion injury by preservation of mitochondrial functionPreventing ischemic brain injury after sudden cardiac arrest using NO inhalationATS Core Curriculum 2016: Part II. Adult Critical Care Medicine.A Comparison of Inhaled Nitric Oxide Versus Inhaled Epoprostenol for Acute Pulmonary Hypertension Following Cardiac Surgery.Effect of nitric oxide on oxygenation and mortality in acute lung injury: systematic review and meta-analysis.Nitrite-generated NO circumvents dysregulated arginine/NOS signaling to protect against intimal hyperplasia in Sprague-Dawley ratsInhaled nitric oxide for the adjunctive therapy of severe malaria: protocol for a randomized controlled trial.Effect of acute arteriolar vasodilation on capacitance and resistance in pulmonary arterial hypertension.Inhaled iloprost for patients with precapillary pulmonary hypertension and right-side heart failurePulmonary vascular and right ventricular dysfunction in adult critical care: current and emerging options for management: a systematic literature review.Therapeutic strategies for severe acute lung injuryPathophysiology of pulmonary hypertension in acute lung injury.Recent developments in nitric oxide donor drugs.Acute lung injury and acute respiratory distress syndrome: experimental and clinical investigations.Nitric oxide: considerations for the treatment of ischemic stroke.Methemoglobin and nitric oxide therapy in Ugandan children hospitalized for febrile illness: results from a prospective cohort study and randomized double-blind placebo-controlled trial.Obesity and ARDS.Inhaled nitric oxide as adjunctive therapy for severe malaria: a randomized controlled trialPathogenic mechanisms of pulmonary arterial hypertension.The role of nitric oxide in mediating tumour blood flow.The linear relationship between systolic pulmonary artery pressure and mean pulmonary artery pressure is maintained regardless of autonomic or rhythm disturbancesNonventilatory treatments for acute lung injury and ARDS.Brief periods of nitric oxide inhalation protect against myocardial ischemia-reperfusion injuryAn injection and mixing element for delivery and monitoring of inhaled nitric oxide.Arginase Inhibition Restores Peroxynitrite-Induced Endothelial Dysfunction via L-Arginine-Dependent Endothelial Nitric Oxide Synthase PhosphorylationRole of iNO in the modulation of pulmonary vascular resistance.Eisenmenger Syndrome in Pregnancy.
P2860
Q26849724-9B7C7498-D4EE-486B-8AFA-0508B4D859ECQ27009276-FC047C14-848F-4081-A352-5F464F13EADBQ27013107-F60628DC-74A2-4E46-81E6-17ACCA5C2055Q27026522-66EDB088-58C5-42F8-A81F-2981B8D64F7AQ27687091-8DAE87EF-C6FC-450E-A87C-FE0C633C4878Q28067343-F313DC58-4055-449C-A902-1AB2398AA1B4Q28087535-12465705-463A-4540-A493-6B8CF9C40DE3Q28396562-678A30FE-19DA-4369-8846-5C20C8E8793CQ28397692-95347342-6440-4BBE-89AF-84A543D190E7Q30445314-70D6A82A-3F87-42E3-8E80-AA7DEFCA9960Q30475217-E1D1991E-E99A-4158-B717-1CA4881F2EDFQ30476296-073FA861-672F-4D9F-8165-B9E7B7493AF7Q30479924-AAE6CB16-AF68-4ED1-A1DF-2D00A910EC7BQ30480176-7AD997CA-7005-4106-B80F-CBD1C1A0C6EFQ33752212-947F4AD6-4C15-4E99-A276-5A3EA861996CQ33772360-607B6CA9-7C4F-41E9-9AC8-44FDB33472CDQ34496895-9430F14E-FC5C-447A-915C-1D76C638E995Q34612107-75BEE43F-0EBC-4976-A00A-76CCF9690685Q34755179-49793E32-28AD-4422-936B-A8914F3513B0Q35150645-2437B990-8066-4738-87AE-EF949808747BQ35298544-14E8F83D-9D94-4993-9BAC-4C3B4D92C866Q35302365-7766AA0A-A4F3-4CE5-BE40-53B350978622Q35559191-04A6136A-0952-41D9-95A3-FE9ED4842044Q35920405-368820B2-BB16-4B29-8E12-7DF1D0F17AF6Q35994453-71490E73-EEFA-433A-AA4F-E8E38FB07A23Q36052815-A2A2D07F-7312-4901-AFDA-F717CB0A44CFQ36077214-657D1D11-BF36-4365-B24E-51BC27D934CDQ36079329-6D04C2A8-6733-404C-82A5-5B4E7AA89E2FQ36183209-557CB0E0-A478-41A9-B47C-A108EAA43233Q36212673-916AA62D-BBD4-4845-96CE-8E19730900C9Q36223174-00C0EDC3-7730-493D-88C6-D77A7D770650Q36447388-E64DA2E3-AFAD-48E4-9D7D-69FC2BD1B551Q36596676-2D0C54C4-1032-4F59-8455-7B158337650FQ36749136-C1F53AD1-EB8C-4C57-98DE-2D325A993BBCQ36758874-2F5CC61F-4767-4557-80C0-517B47535109Q37077525-C33FF3ED-50B1-422E-882A-0C4E05AA18CCQ37216093-C4215D46-84F0-4238-AAFA-B45968163951Q37231836-BF0BB50D-9021-4CD1-AA18-6B9729D384B5Q37341687-A6007D3A-BCBE-45D2-BD81-CD06D607CB88Q37391582-456148E0-ECD7-4676-ACBF-F228FF76DEAE
P2860
description
2005 nî lūn-bûn
@nan
2005 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Inhaled nitric oxide therapy in adults.
@ast
Inhaled nitric oxide therapy in adults.
@en
Inhaled nitric oxide therapy in adults.
@nl
type
label
Inhaled nitric oxide therapy in adults.
@ast
Inhaled nitric oxide therapy in adults.
@en
Inhaled nitric oxide therapy in adults.
@nl
prefLabel
Inhaled nitric oxide therapy in adults.
@ast
Inhaled nitric oxide therapy in adults.
@en
Inhaled nitric oxide therapy in adults.
@nl
P356
P1476
Inhaled nitric oxide therapy in adults.
@en
P2093
Mark J D Griffiths
Timothy W Evans
P304
P356
10.1056/NEJMRA051884
P407
P577
2005-12-01T00:00:00Z